journal
https://read.qxmd.com/read/38777980/robotic-surgery-for-head-and-neck-tumors-what-are-the-current-applications
#21
REVIEW
Po Ling Catherine Chan, Eddy Wai Yeung Wong, Jason Ying Kuen Chan
BACKGROUND: The journey from radical treatments to the precision of robotic surgery underscores a commitment to innovation and patient-centered care in the field of head and neck oncology. PURPOSE OF REVIEW: This article provides a comprehensive overview that not only informs but also stimulates ongoing discourse and investigation into the optimization of patient care through robotic surgery. The literature on current robotic applications within head and neck region was systematically reviewed...
May 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38777979/communication-between-caregivers-of-adults-with-cancer-and-healthcare-professionals-a-review-of-communication-experiences-associated-factors-outcomes-and-interventions
#22
REVIEW
Ying Wang, Christopher L Seplaki, Sally A Norton, AnnaLynn M Williams, Sindhuja Kadambi, Kah Poh Loh
PURPOSE OF REVIEW: Family/unpaid caregivers play an important role in cancer care. This review aims to summarize caregiver communication experiences with healthcare professionals (HCPs). RECENT FINDINGS: The Caregiver-Centered Communication model defines five core functions that HCPs should achieve when interacting with caregivers, including fostering relationships, exchanging information, recognizing and responding to caregiver emotions, aiding in decision making, and assisting in patient care management...
May 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38776011/advancements-in-the-management-of-synchronous-colorectal-liver-metastases-a-comprehensive-review-of-surgical-systemic-and-local-treatment-modalities
#23
REVIEW
Beliz Bahar Karaoğlan, Diğdem Kuru Öz, Mine Soylu Araz, Cihangir Akyol, Güngör Utkan
PURPOSE OF REVIEW: This review addresses the current landscape of colorectal cancer (CRC) with a focus on liver metastases, the third most common cancer globally. It explores recent findings in treatment strategies, emphasizing the dynamic interplay between surgery, systemic chemotherapy, and local therapies for synchronous colorectal liver metastases (CRLMs). RECENT FINDINGS: Highlighting the role of advanced imaging, the review underscores the significance of contrast-enhanced MRI in surgical planning for CRLMs...
May 22, 2024: Current Oncology Reports
https://read.qxmd.com/read/38771469/anamorelin-for-the-treatment-of-cancer-anorexia-cachexia-syndrome
#24
REVIEW
Rony Dev, Koji Amano, Tateaki Naito, Egidio Del Fabbro
PURPOSE OF REVIEW: The following review will highlight the development of anamorelin to treat cancer anorexia-cachexia syndrome (CACS) including the potential benefits, limitations, and future directions. RECENT FINDINGS: Ghrelin, a 28-amino acid peptide hormone, is secreted by the stomach mucosa and regulates appetite, promotes lipogenesis, increases body weight, improves gastric motility, reduces catabolic wasting and inflammation. Several randomized, double-blind, placebo-controlled clinical trials evaluating anamorelin, a ghrelin agonist, for the treatment of CACS have reported improvement in appetite and body composition including both lean body and fat mass; however, most studies noted no improvement in physical function as assessed by measuring non-dominant hand-grip strength...
May 21, 2024: Current Oncology Reports
https://read.qxmd.com/read/38767829/percutaneous-ablation-of-t1b-renal-cell-carcinoma-an-overview
#25
REVIEW
Alyssa Knight, Andrew J Gunn
PURPOSE OF REVIEW: There is increasing incidence of renal cell carcinoma (RCC) with multiple treatment options currently available. The purpose of this review is to outline patient selection and technical approaches and present the current literature for percutaneous ablation of T1b (4.1-7 cm) RCC. RECENT FINDINGS: An increasing number of retrospective studies and meta-analyses have evaluated the use of percutaneous ablation for T1b RCC. Overall, these studies tend to show that percutaneous ablation in this patient population is feasible...
May 20, 2024: Current Oncology Reports
https://read.qxmd.com/read/38761302/personalized-treatment-of-multiple-myeloma-in-frail-patients
#26
REVIEW
Jodi J Lipof, Nadine Abdallah, Brea Lipe
PURPOSE OF REVIEW: As the treatment landscape for multiple myeloma (MM) continues to expand at a rapid pace, management of older adults and frail patients becomes increasingly challenging. As these patients have traditionally been underrepresented on clinical trials, there is limited guidance on the optimal approach to frail patients with newly diagnosed multiple myeloma (NDMM) or relapsed and refractory multiple myeloma (RRMM). RECENT FINDINGS: Frailty is an independent predictor of tolerability and response to antineoplastic treatment...
May 18, 2024: Current Oncology Reports
https://read.qxmd.com/read/38748364/axillary-management-how-much-is-too-much
#27
REVIEW
Nicci Owusu-Brackett, Benjin Facer, Dionisia Quiroga, Ashley Pariser, Michael Grimm, Sasha Beyer, Sachin Jhawar, Bridget A Oppong
PURPOSE OF REVIEW: To review the current management of the axilla in breast cancer. RECENT FINDINGS: Axillary dissection is no longer indicated in patients with clinically node-negative axilla with 1-2 positive sentinel lymph nodes following upfront surgery or in patients with clinically node-negative axilla following neoadjuvant chemotherapy. Breast cancer has evolved away from routine axillary clearance to the less invasive sentinel lymph node biopsy to now complete omission of axillary sampling in select patients...
May 15, 2024: Current Oncology Reports
https://read.qxmd.com/read/38733465/integrative-medicine-across-the-pediatric-cancer-care-trajectory-a-narrative-review
#28
REVIEW
Eran Ben-Arye, Noah Samuels, Georg Seifert, Orit Gressel, Raviv Peleg, Miek Jong
PURPOSE OF THE REVIEW: Children and adolescents with cancer, along with their parents and other informal caregivers, often report using complementary and alternative medicine (CAM) during active oncology and hemato-oncology treatment. Some adopt an "alternative" approach to conventional medical care, which often entails the use of these practices without the knowledge of the treating pediatrician. In contrast, many others search for consultation provided by a pediatric integrative oncology (IO) practitioner working with the conventional medical team...
May 11, 2024: Current Oncology Reports
https://read.qxmd.com/read/38713311/cdk4-6-inhibitors-the-devil-is-in-the-detail
#29
REVIEW
Tara Magge, Sneha Rajendran, Adam M Brufsky, Julia Foldi
PURPOSE OF REVIEW: Update on the most recent clinical evidence on CDK4/6 inhibitors (CDK4/6i) in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor (HER)2-negative breast cancer. RECENT FINDINGS: Over the past decade, CDK4/6i have become part of the standard of care treatment of patients with both metastatic and high-risk early HR + /HER2- breast cancers. The three available CDK4/6i (palbociclib, ribociclib and abemaciclib) have been extensively studied in combination with endocrine therapy (ET) in metastatic breast cancer (mBC) with consistent prolongation of progression free survival; however, ribociclib has emerged as the preferred first line agent in mBC given overall survival benefit over endocrine monotherapy...
May 7, 2024: Current Oncology Reports
https://read.qxmd.com/read/38709422/past-present-and-future-therapeutic-strategies-for-nf-1-associated-tumors
#30
REVIEW
Brian Na, Shilp R Shah, Harish N Vasudevan
PURPOSE OF REVIEW: Neurofibromatosis type 1 (NF-1) is a cancer predisposition syndrome caused by mutations in the NF1 tumor suppressor gene that encodes the neurofibromin protein, which functions as a negative regulator of Ras signaling. We review the past, current, and future state of therapeutic strategies for tumors associated with NF-1. RECENT FINDINGS: Therapeutic efforts for NF-1-associated tumors have centered around inhibiting Ras output, leading to the clinical success of downstream MEK inhibition for plexiform neurofibromas and low-grade gliomas...
May 6, 2024: Current Oncology Reports
https://read.qxmd.com/read/38683254/integrative-approaches-for-cancer-pain-management
#31
REVIEW
Reema Sabeeha Martini, Terrell Brown, Vinita Singh, Anna Woodbury
PURPOSE OF REVIEW: The goal of this review is to summarize updates to the broad array of complementary therapies available for cancer pain. This paper will serve as a reference for clinicians managing pain in cancer patients. RECENT FINDINGS: Patients are embracing integrative therapies in growing numbers; clinicians must be prepared to incorporate these therapies into patients' existing treatment regimens. This requires knowledge regarding risks, benefits, and potential interactions with existing cancer therapies...
April 29, 2024: Current Oncology Reports
https://read.qxmd.com/read/38676789/minimal-residual-disease-adapted-therapy-in-multiple-myeloma-current-evidence-and-opinions
#32
REVIEW
Mina Meseha, James Hoffman, Dickran Kazandjian, Ola Landgren, Benjamin Diamond
PURPOSE OF REVIEW: Multiple myeloma (MM) is a biologically heterogeneous malignancy with relatively uniform treatment paradigms. This review aims to assess the growing role of Minimal Residual Disease (MRD) assessment in facilitating response-adapted therapeutic decision making to individualize therapy in MM. RECENT FINDINGS: MRD has been repeatedly demonstrated to provide strong prognostic information, superseding traditional IMWG response criteria. The use of MRD to modulate therapy remains controversial...
April 27, 2024: Current Oncology Reports
https://read.qxmd.com/read/38668924/non-squamous-cancers-of-the-larynx
#33
REVIEW
H Bengu Cobanoglu, Erdal Rahman Koprucu
PURPOSE OF REVIEW: Although non-squamous tumors of the larynx are really rare, they may not always be viewed from the same perspective in the multidisciplinary treatment approach once the diagnosis is made. In this review, non-squamous tumors of the larynx and current approaches in treatment will be discussed. RECENT FINDINGS: When the studies and meta-analyses presented in the last 5 years are evaluated, it is seen that these tumors usually show non-specific symptoms...
April 26, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652426/antibody-drug-conjugates-in-urological-cancers-a-review-of-the-current-landscape
#34
REVIEW
Aruni Ghose, Patricia Lapitan, Vedika Apte, Adheesh Ghosh, Abhinav Kandala, Sreejana Basu, Jo Parkes, Sayali D Shinde, Stergios Boussios, Anand Sharma, Prantik Das, Nikhil Vasdev, Sara E Rebuzzi, Yüksel Ürün, Ravindran Kanesvaran, Akash Maniam, Giuseppe L Banna
PURPOSE OF REVIEW: Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions in antibody-drug conjugate (ADC) development, emphasising their transformative potential in cancer care. RECENT FINDINGS: ADCs have advanced from hematologic to solid tumours, notably in breast cancer, and are now pivotal in metastatic urological cancers as both monotherapies and in combination regimens, underscored by the FDA's approval of enfortumab vedotin and sacituzumab govitecan for metastatic urothelial cancer...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652425/navigating-breast-cancer-oligometastasis-and-oligoprogression-current-landscape-and-future-directions
#35
REVIEW
Stephanie M Yoon, Jose G Bazan
PURPOSE: We examine the potential for curative approaches among metastatic breast cancer (MBC) patients by exploring the recent literature on local ablative therapies like surgery and stereotactic body radiation therapy (SBRT) in patients with oligometastatic (OM) breast cancer. We also cover therapies for MBC patients with oligoprogressive (OP) disease. KEY FINDINGS: Surgery and SBRT have been studied for OM and OP breast cancer, mainly in retrospective or non-randomized trials...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652424/the-growing-role-of-digital-health-tools-in-the-care-of-patients-with-cancer-current-use-future-opportunities-and-barriers-to-effective-implementation
#36
REVIEW
Robert Haemmerle, Jonas Paludo, Tufia C Haddad, Joshua C Pritchett
PURPOSE OF REVIEW: This article aims to describe the ways in which digital health technologies are currently being used to improve the delivery of cancer care, highlight opportunities to expand their use, and discuss barriers to effective and equitable implementation. RECENT FINDINGS: The utilization of digital health tools and development of novel care delivery models that leverage such tools is expanding. Recent studies have shown feasibility and increased implementation in the setting of oncologic care...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38647995/update-on-percutaneous-ablation-for-sarcoma
#37
REVIEW
Ahmad Parvinian, Scott M Thompson, John J Schmitz, Brian T Welch, Rebecca Hibbert, Daniel A Adamo, A Nicholas Kurup
PURPOSE OF REVIEW: To provide an update on the current state of percutaneous thermal ablation in the treatment of sarcoma. RECENT FINDINGS: Data continue to accrue in support of ablation for local control and palliation of specific sarcoma subtypes such as extra-abdominal desmoid fibromatosis and for broader indications such as the treatment of oligometastatic disease. The synergistic possibilities of various combination therapies such as cryoablation and immunotherapy represent intriguing areas of active investigation...
April 22, 2024: Current Oncology Reports
https://read.qxmd.com/read/38647994/current-status-of-partial-laryngeal-surgery-for-advanced-laryngeal-cancer-when-and-why
#38
REVIEW
Erika Crosetti, Marco Fantini, Ilaria Bertotto, Andy Bertolin, Giulia Arrigoni, Andrea Lorenzi, Giovanni Succo
PURPOSE OF REVIEW: This paper aims to evaluate the evolution and current status of partial laryngeal surgery in the treatment of advanced laryngeal cancer (LC). Specifically, recent progress in the selection of both patients and tumors, together with surgical and rehabilitation innovations, have contributed to balancing oncological control with the maintenance of quality of life in naïve and radiorecurrent patients. The main aspect is represented by the recognized role of open partial horizontal laryngectomies (OPHLs) in this new era of laryngeal cancer treatment...
April 22, 2024: Current Oncology Reports
https://read.qxmd.com/read/38639793/changing-the-perspective-on-fertility-preservation-for-women-with-metastatic-or-advanced-stage-cancer
#39
REVIEW
Mary Kathryn Abel, Ange Wang, Joseph M Letourneau, Michelle E Melisko, Marcelle I Cedars, Mitchell P Rosen
PURPOSE OF REVIEW: In this Perspective we share the personal story of a 33-year-old patient diagnosed with metastatic breast cancer and her journey through fertility preservation, surrogacy, and eventually motherhood, highlighting misconceptions about fertility preservation in this population. RECENT FINDINGS: There are nearly 1 million women under the age of 50 diagnosed and living with cancer in the USA. These patients are met with life-altering decisions, including those that may limit their reproductive ability...
April 19, 2024: Current Oncology Reports
https://read.qxmd.com/read/38625653/ablation-of-kidney-tumors-in-patients-with-substantial-kidney-impairment-current-status
#40
REVIEW
Toshihiro Iguchi, Yusuke Matsui, Koji Tomita, Mayu Uka, Noriyuki Umakoshi, Takahiro Kawabata, Hideo Gobara, Motoo Araki, Takao Hiraki
PURPOSE OF REVIEW: To review the current status of kidney tumor ablation in patients with substantial kidney impairment. RECENT FINDINGS: Few reports of kidney tumor ablation in such patients have recently been published. The reported prevalence of patients with stage 4 or 5 chronic kidney disease (CKD) among patients undergoing ablation is 2.0%-10%. In patients with stage 4 or 5 CKD, local tumor control rates were 88%-100%. The effect of ablation on CKD stage is unclear, and the observed deteriorations in kidney function are consistent with both the effect of cryoablation and the natural course of advanced CKD...
April 16, 2024: Current Oncology Reports
journal
journal
34702
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.